{"meta":{"query_hash":"33b245e19481","filters":{"venue":"Journal of Molecular Chemistry."},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/33b245e19481","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Molecular+Chemistry."},"results":[{"id":"W4410047027","doi":"10.62110/sciencein.jmc.2025.1206","title":"Novel small molecule drugs approved by FDA in 2024 for cancer therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Molecular Chemistry.","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer therapy; Cancer drugs; Cancer; Medical physics; Internal medicine","score_opus":0.007613639462595399,"score_gpt":0.2513824018588955,"score_spread":0.24376876239630008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410047027","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043749273,0.31834784,0.009723619,0.0945842,0.031396654,0.001346968,0.013829772,0.0017453501,0.48527634],"genre_scores_gemma":[0.2184046,0.21005036,0.018897865,0.081024,0.007922874,0.0011319047,0.016908307,0.0003037704,0.44535628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995171,0.00008217725,0.000039142913,0.00004683864,0.00023026924,0.00008438862],"domain_scores_gemma":[0.99952066,0.00006091642,0.00008529114,0.000025448484,0.00019318292,0.00011450372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008513611,0.00047256897,0.00044632875,0.0008327445,0.00043492165,0.0014372735,0.00047999236,0.001788399,0.027761899],"category_scores_gemma":[0.001050651,0.00018560461,0.00073002104,0.00063574815,0.00033608993,0.00059092295,0.0003914728,0.0017854704,0.009655737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008519043,0.0003582318,0.0014904022,0.0007577055,0.00007525137,0.00077332737,0.000051001603,0.00028136364,0.02129539,0.011252131,0.3049575,0.65785575],"study_design_scores_gemma":[0.00024781207,0.00061954587,0.0015774112,0.00017208188,0.000036773043,0.00071828155,0.000018812128,0.00015179902,0.0034821453,0.0010145296,0.9919469,0.000013877202],"about_ca_topic_score_codex":0.0011872912,"about_ca_topic_score_gemma":0.004986668,"teacher_disagreement_score":0.027761899,"about_ca_system_score_codex":0.0009312131,"about_ca_system_score_gemma":0.0021869005,"threshold_uncertainty_score":0.09287286},"labels":[],"label_agreement":null}]}